Literature DB >> 16043701

Possible role of the 11-cis-retinyl conformation in controlling the dual decay processes of excited rhodopsin.

Robert S H Liu1, George S Hammond, Taraneh Mirzadegan.   

Abstract

In this work, we examine how the reported dual decay processes of rhodopsin and binding site stereospecificity can be accounted for by the recently available crystal structure of rhodopsin. Arguments are presented for possible presence of two rhodopsin "rotamers" that fit within the binding cavity. Directed pathways of decay could account for the observed excited decay processes. We summarize evidence for the possible existence of two different ground-state configurations that give rise to two different excited species.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16043701      PMCID: PMC1182415          DOI: 10.1073/pnas.0501665102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

1.  Wavelength dependent cis-trans isomerization in vision.

Authors:  J E Kim; M J Tauber; R A Mathies
Journal:  Biochemistry       Date:  2001-11-20       Impact factor: 3.162

Review 2.  Advances in determination of a high-resolution three-dimensional structure of rhodopsin, a model of G-protein-coupled receptors (GPCRs).

Authors:  D C Teller; T Okada; C A Behnke; K Palczewski; R E Stenkamp
Journal:  Biochemistry       Date:  2001-07-03       Impact factor: 3.162

3.  Modelling of photointermediates suggests a mechanism of the flip of the beta-ionone moiety of the retinylidene chromophore in the rhodopsin photocascade.

Authors:  Masaji Ishiguro; Takahiro Hirano; Yoshiaki Oyama
Journal:  Chembiochem       Date:  2003-03-03       Impact factor: 3.164

4.  Structural heterogeneity of cryotrapped intermediates in the bacterial blue light photoreceptor, photoactive yellow protein.

Authors:  Spencer Anderson; Vukica Srajer; Keith Moffat
Journal:  Photochem Photobiol       Date:  2004 Jul-Aug       Impact factor: 3.421

5.  The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structure.

Authors:  Tetsuji Okada; Minoru Sugihara; Ana-Nicoleta Bondar; Marcus Elstner; Peter Entel; Volker Buss
Journal:  J Mol Biol       Date:  2004-09-10       Impact factor: 5.469

6.  Conformation of retinal isomers.

Authors:  R Rowan; A Warshel; B D Sykes; M Karplus
Journal:  Biochemistry       Date:  1974-02-26       Impact factor: 3.162

7.  Vibrationally coherent photochemistry in the femtosecond primary event of vision.

Authors:  Q Wang; R W Schoenlein; L A Peteanu; R A Mathies; C V Shank
Journal:  Science       Date:  1994-10-21       Impact factor: 47.728

8.  Recognition of opsin to the longitudinal length of retinal isomers in the formation of rhodopsin.

Authors:  H Matsumoto; T Yoshizawa
Journal:  Vision Res       Date:  1978       Impact factor: 1.886

9.  Solution and biologically relevant conformations of enantiomeric 11-cis-locked cyclopropyl retinals.

Authors:  Yukari Fujimoto; Nathan Fishkin; Gennaro Pescitelli; John Decatur; Nina Berova; Koji Nakanishi
Journal:  J Am Chem Soc       Date:  2002-06-26       Impact factor: 15.419

10.  X-ray diffraction analysis of nonequilibrium states in crystals: observation of an unstable conformer in flash-cooled crystals.

Authors:  Jun Harada; Keiichiro Ogawa
Journal:  J Am Chem Soc       Date:  2004-03-24       Impact factor: 15.419

View more
  3 in total

1.  Femtochemistry of orange II in solution and in chemical and biological nanocavities.

Authors:  Abderrazzak Douhal; Mikel Sanz; Laura Tormo
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

2.  Binding of rhodopsin and rhodopsin analogues to transducin, rhodopsin kinase and arrestin-1.

Authors:  Nelson A Araujo; Carlos E Sanz-Rodríguez; José Bubis
Journal:  World J Biol Chem       Date:  2014-05-26

3.  The molecular structure of a curl-shaped retinal isomer.

Authors:  Robert Send; Dage Sundholm
Journal:  J Mol Model       Date:  2008-03-20       Impact factor: 1.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.